Amid an exponential rise in Covid-19 cases, Delhi has been placed under curfew from Monday night till April 26 morning, Chief Minister Arvind Kejriwal announced on Monday.

दिल्ली में तेज़ी से बढ़ते कोरोना मामलों के मद्देनज़र एक महत्वपूर्ण घोषणा | Press Conference | LIVE https://t.co/zAECIEcZ53

— Arvind Kejriwal (@ArvindKejriwal) April 19, 2021

The decision was taken during a meeting attended by CM Kejriwal, L-G Anil Baijal, Delhi Police Commissioner SN Srivastava, Delhi's deputy CM Manish Sisodia, Health Minister Satyendra Jain and other officials. Sources told India TV that a decision on extending the curfew for one more week was proposed by Kejriwal which the L-G approved. The city government had last week announced curfew on weekend to arrest the spread of virus.

Essential services, however, will be exempted during the weeklong curfew, sources said, adding that all private and government offices will work remotely.

Delhi on Sunday recorded the biggest jump in its daily COVID-19 tally with 25,462 fresh cases, while the positivity rate shot up to 29.74 per cent -- meaning almost every third sample being tested in the city is turning out to be positive. Authorities reported 161 deaths due to the disease in the last 24 hours. A day ago, 24,375 COVID-19 cases and 167 deaths were reported in the city.

As the situation turned serious every passing hour, Kejriwal shot off letters to Prime Minister Narendra Modi and Union Commerce and Industries Minister Piyush Goyal urging them to ramp up bed capacity in central government-run hospitals and to ensure uninterrupted supply of medical oxygen.

"The COVID situation has become very serious in Delhi. There is a huge shortage of beds and oxygen. I request that at least 7,000 out of 10,000 beds in central government hospitals in Delhi be reserved for COVID patients and oxygen be immediately provided in Delhi," he wrote in the letter to PM Modi.

Meanwhile, the city government on Monday deployed two teams of officers to monitor procurement and supply of oxygen and the Remdesivir drug amid a shortage of both following an exponential rise in COVID-19 cases.